objective: RNA splicing is an essential step in regulating the gene posttranscriptional expression. Serine/arginine-rich splicing factors (SRSFs) are splicing regulators with vital roles in various tumors. Nevertheless, the expression patterns and functions of SRSFs in hepatocellular carcinoma (HCC) are not fully understood.
methods: Flow cytometry and immunofluorescent staining were used to determine the CD8T cell infiltration. Orthotopic HCC model, lung metastasis model, DEN/CCl model, Srsf10 model, and Srsf10 model were established to evaluate the role of SRSF10 in HCC and the efficacy of combination treatment.
results: SRSF10 was one of the most survival-relevant genes among SRSF members and was an independ... More
objective: RNA splicing is an essential step in regulating the gene posttranscriptional expression. Serine/arginine-rich splicing factors (SRSFs) are splicing regulators with vital roles in various tumors. Nevertheless, the expression patterns and functions of SRSFs in hepatocellular carcinoma (HCC) are not fully understood.
methods: Flow cytometry and immunofluorescent staining were used to determine the CD8T cell infiltration. Orthotopic HCC model, lung metastasis model, DEN/CCl model, Srsf10 model, and Srsf10 model were established to evaluate the role of SRSF10 in HCC and the efficacy of combination treatment.
results: SRSF10 was one of the most survival-relevant genes among SRSF members and was an independent prognostic factor for HCC. SRSF10 facilitated HCC growth and metastasis by suppressing CD8T cell infiltration. Mechanistically, SRSF10 down-regulated the p53 protein by preventing the exon 6 skipping (exon 7 in mouse) mediated degradation of MDM4 transcript, thus inhibiting CD8T cell infiltration. Elimination of CD8T cells or overexpression of MDM4 removed the inhibitory role of SRSF10 knockdown in HCC growth and metastasis. SRSF10 also inhibited the IFNα/γ signaling pathway and promoted the HIF1α-mediated up-regulation of PD-L1 in HCC. Hepatocyte-specific SRSF10 deficiency alleviated the DEN/CCl-induced HCC progression and metastasis, whereas hepatocyte-specific SRSF10 overexpression deteriorated these effects. Finally, SRSF10 knockdown enhanced the anti-PD-L1-mediated anti-tumor activity.
conclusions: SRSF10 promoted HCC growth and metastasis by repressing CD8T cell infiltration mediated by the MDM4-p53 axis. Furthermore, SRSF10 suppressed the IFNα/γ signaling pathway and induced the HIF1α signal mediated PD-L1 up-regulation. Targeting SRSF10 combined with anti-PD-L1 therapy showed promising efficacy.
